Keutzer Timothy 4
4 · Spero Therapeutics, Inc. · Filed Aug 30, 2023
Insider Transaction Report
Form 4
Keutzer Timothy
Chief Operating Officer
Transactions
- Sale
Common Stock
2023-08-28$1.26/sh−1,854$2,336→ 325,290 total
Footnotes (1)
- [F1]The reported transaction is a sale of common stock effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted to the Reporting Person on August 26, 2021 pursuant to a "sell to cover" provision included in the RSU Agreement.